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Abstract 
Several current cancer therapies, including photodynamic therapy (PDT), use reactive oxygen 
species (ROS) to induce tumor cell apoptosis and necrosis. Photocatalytic tungsten trioxide 
platinum (WO3/Pt) nanoparticles constitute a novel therapeutic agent for promoting hydroxyl 
radical production during PDT. In the present study, we develop a targetable and chemically 
active form of WO3/Pt nanoparticles for applications in cancer treatment. Orthorhombic WO3 
nanoparticles platinized at basic pH were used due to their exceptional catalytic activity under 
visible light illumination. When modified with tumor specific amino ligands for targeted delivery, 
these nanoparticles continued to express tumor toxicity via ROS production. The ability to use 






Nanoparticles are ideally sized to interact with cell surfaces and biological systems at the 
molecular level. For this reason, they have been tailored with targeting peptides to function as 
drug delivery systems. For example, gold nanoparticles conjugated with tumor necrosis factor 
and paclitaxel, a tumor targeting moiety and an anticancer drug, cause tumor regression in 
mice.8 However, metal oxide nanoparticles may also function as therapeutic agents because of 
their radical scavenging and anticancer properties. By catalyzing redox reactions, metal oxide 
nanoparticles can transfer electrons between species, creating or detoxifying reactive oxygen 
species (ROS). ROS are responsible for a number of diseases including cardiovascular and 
neurodegenerative diseases. While excessive ROS can induce oxidative stress and cause 
significant cell damage, basal levels of ROS are also necessary for cellular homeostasis.7 
Therefore, metal oxide nanoparticles are suitable candidates for exogenously controlling ROS 
levels. Here, we explore using photocatalytic WO3/Pt nanoparticles to elevate ROS levels in 
tumor cells for improved cancer treatment. 
WO3 are photocatalytic nanoparticles that generate hydroxyl radicals when stimulated 
with visible light. Hydroxyl radicals are a reactive oxygen species that can cause significant 
damage to intracellular molecules and induce cell apoptosis and necrosis.9 When loaded with 
platinum, WO3 nanoparticles demonstrate enhanced photocatalytic activity and increased ROS 
production.1 Thus, WO3/Pt nanoparticles may be used to promote ROS-induced tumor cell 
death. 
Current cancer treatments that rely on ROS to eradicate tumor cells are suboptimal. In 
photodynamic therapy (PDT), photosensitizer dyes accumulate in tumor tissue and generate 
reactive oxygen species (ROS) upon exposure to light. However, traditional first and second 
generation photosensitizers are hydrophobic and show poor tumor selectivity.2,9 Moreover, they 
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are also readily degraded by ROS produced during illumination. As a result, photosensitizers 
limit the duration of therapy since their half-lives typically lie on the order of minutes to hours. 
WO3/Pt photocatalytic nanoparticles offer a critical advantage for improving PDT in 
cancer patients. For one, WO3/Pt nanoparticles do not photobleach due to their inorganic 
nature, allowing for increased ROS yields over time. This could potentially improve patient 
outcomes by prolonging the treatment period. For another, WO3/Pt nanoparticles can be 
functionalized to target tumor cells through surface modifications. Indeed, the surface chemistry 
of WO3/Pt enables conjugation of tumor specific amino ligands, such as folic acid. Folic acid 
binds folate receptor which is overexpressed in cancer cells.6 Therefore, active targeting of 
WO3/Pt nanoparticles could increase selectivity relative to photosensitizers. Finally, WO3/Pt 
nanoparticles have X-ray scattering properties that could be used to track nanoparticle 
movements in patients using micro-CT scans. 
Among semiconductors, WO3/Pt nanoparticles are ideal candidates for PDT. For one, 
their band gap is small enough for visible-light activation (2.4–2.8 eV).11 By contrast, UV light-
activated semiconductors such as TiO2 are unfit for PDT since UV radiation causes DNA 
damage. For another, WO3/Pt nanoparticles demonstrate high efficiency for decomposition of 
organic compounds due to the high oxidation power of their valence band holes.11 This 
suggests that WO3/Pt nanoparticles would be active photocatalysts in a biological environment.  
Importantly, WO3 is nontoxic and has exceptional stability in aqueous media over a wide 
pH range.7 Moreover, the median lethal dose of WO3 (1059 mg/kg) is greater than that of 
caffeine (150-200 mg), suggesting that WO3 nanoparticles are safe to use in appropriate 
doses.10 Although the toxicity of WO3/Pt nanoparticles has not been established, recent studies 
indicate that WO3/Pt nanoparticles have no effect on ocular structures when injected into the 
anterior chamber of a mouse eye.10 
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Taken together, WO3/Pt nanoparticles may serve as an alternative to current 
photosensitizers for treatment of cancer using PDT. Interestingly, the literature on WO3/Pt  
nanoparticles has focused on environmental solutions, and the biomedical applications of 
WO3/Pt photocatalysts remain unexplored.
5 With a view toward developing nanotherapeutics, 






Materials and Methods 
Photoanode activity 
We assessed the photoanode activity of WO3/Pt nanoparticles by monitoring the degradation of 
methylene blue over time. A suspension of 0.5 mg/mL of WO3/Pt nanoparticles in 46.9 mM 
methylene blue was illuminated with a visible light source. Aliquots were taken at time intervals 
and centrifuged to remove nanoparticles. Supernatants were transferred to Costar plates and 
absorbance was read at 660 nm with a plate reader (Molecular Devices). 
Photocathode activity  
We assessed the photocathode activity of WO3/Pt nanoparticles by using coumarin as a 
fluorescent probe to monitor hydroxyl radical production. Hydroxyl radicals react with coumarin 
to form a fluorescent compound. A suspension of 0.5 mg/mL of WO3/Pt nanoparticles in 1mM 
coumarin (pH 3) was illuminated with a visible light source for ninety minutes. Aliquots were 
sampled at eight different time points and centrifuged to remove nanoparticles. Supernatants 
were transferred to Costar plates and read with a FlexStation II device (Molecular Devices) with 
excitation at 332 nm emission at 460 nm. 
Dissolved oxygen measurements 
We assessed the ability of a panel of biomolecules to act as substrates for WO3/Pt 
nanoparticles by monitoring oxygen utilization. A suspension of 1 mg/mL of WO3/Pt 
nanoparticles in 1mM lysine was illuminated with a visible light source in customized Hach 
(Loveland, CO) BOD bottles at room temperature. Dissolved oxygen was measured using an 
Oakton model DO2700 meter (Cole-Parmer, Vernon Hills, IL) with constant stirring. Arginine, 
glucose, glycerol, citric acid, oxalic acid and uridine were also tested as substrates for the 




We confirmed the conjugation of FA-PEG to WO3/Pt nanoparticles using gel electrophoresis to 
assess nanoparticle electro-kinetic properties. 25 µg of WO3/Pt nanoparticles were loaded per 
well in a 0.4% agarose gel submerged in 1x TAE buffer. Electrophoresis was run at 60 mA for 
one hour. 
Antibody staining 
We confirmed the conjugation of FA-PEG to WO3/Pt nanoparticles using antibody staining. FA-
PEG WO3/Pt nanoparticles in 1% BSA were stained with mouse anti folic acid antibody in a 1:50 
dilution. After sixty minutes, nanoparticles were washed three times with PBS and subsequently 
stained with Alexa Fluoro Goat anti mouse antibody in a 1:50 dilution. Nanoparticles were 
visualized using immunofluorescence microscopy. 
Statistical Analysis 
In vitro data are presented as the mean ± standard deviation. Data were evaluated with 





Crystal structure and platinization pH affect WO3/Pt catalytic activity. 
We evaluated the effect of crystal structure and platinization pH on WO3/Pt catalytic activity. 
Nanoparticles platinized at acidic (pH = 2) and basic (pH = 12) pH were illuminated with light in 
the presence of coumarin for 30 minutes. Fluorescence was measured over time to monitor the 
production of hydroxyl radicals (332/460). At 30 minutes, WO3/Pt nanoparticles platinized at 
basic pH generated significantly more hydroxyl radicals than WO3/Pt nanoparticles platinized at 
acidic pH (p = 0.001). Next, we tested the catalytic activity of orthorhombic and tetragonal 
nanoparticles. After 30 minutes of illumination, orthorhombic nanoparticles incubated with 
coumarin produced significantly more hydroxyl radicals than tetragonal nanoparticles (p = 0.02). 
In the absence of nanoparticles, hydroxyl radicals were not produced (data not shown). 
WO3/Pt nanoparticles use light to degrade organic dyes. 
We evaluated the ability for WO3/Pt nanoparticles to degrade organic dyes under visible light 
illumination. We illuminated WO3/Pt nanoparticles with methylene blue, which has a peak 
absorbance at 660 nm. Degradation of methylene blue was evaluated using spectrophotometry. 
When illuminated in the presence of nanoparticles, methylene blue disappears over time (Figure 
4). In the absence of light or nanoparticles, methylene blue is not degraded (data not shown). 
Biological molecules are substrates for WO3/Pt nanoparticles. 
We conducted oxygen utilization experiments to study the substrate specificity of WO3/Pt 
nanoparticles. Among the biomolecules tested were glucose, lysine, uridine, citric acid, and 
arginine. To determine if biomolecules are substrates for WO3/Pt nanoparticles, we incubated 
them with nanoparticles under illumination. In the absence of substrate, illuminated 
nanoparticles do not consume oxygen (Figure 5, Trace 1). Similarly, in the absence of 
nanoparticles, the substrate lysine does not diminish oxygen levels (Figure 5, Trace 2). In the 
10 
 
dark, nanoparticles incubated with lysine do not consume oxygen (Figure 5, Trace 3). However, 
when nanoparticles are incubated with lysine under visible light illumination, oxygen is depleted 
(Figure 5, Trace 4). Thus, lysine is a substrate for WO3/Pt nanoparticles. Similarly, glucose, 
lysine, uridine, citric acid, and arginine promote oxygen disappearance during nanoparticle 
illumination (Figure 5, Traces 5-10) suggesting that a large panel of biomolecules including 
amino acids, metabolites, and nucleosides are substrates for WO3/Pt nanoparticles. 
WO3/Pt nanoparticles are surface modified with tumor targeting peptides using CDI. 
We functionalized WO3/Pt nanoparticles with folic acid, a tumor specific amino ligand. First, 
WO3/Pt nanoparticles were activated with carbonyldiimidazole (CDI). Then, WO3/Pt 
nanoparticles were reacted with FA-PEG-NH2 to form FA-PEG WO3/Pt nanoparticles (Figure 
6A). Polyethylene glycol was used to stabilize nanoparticle suspensions and prevent 
aggregation. To confirm the linkage of folic acid to nanoparticles, we electrophoresed modified 
and unmodified nanoparticles on a 0.4% agarose gel. FA-PEG coated nanoparticles migrated a 
shorter distance than unmodified nanoparticles, suggesting that FA-PEG alters the electro-
kinetic properties of WO3/Pt nanoparticles (Figure 6C). Moreover, we also stained nanoparticles 
with mouse anti folic acid antibody and Alexa Fluor 488 goat anti mouse antibody. Under 
microscope, FA-PEG coated nanoparticles fluoresced (Figure 6B) whereas unmodified 
nanoparticles did not (data not shown). These results confirm that CDI effectively conjugates 
FA-PEG to WO3/Pt nanoparticles. In subsequent conjugations, CDI was used to link PLL and 
PVA to WO3/Pt nanoparticles. After conjugation, FA-NHS ester was reacted with amino groups 
on PLL and PVA to form FA-PLL and FA-PVA WO3/Pt nanoparticles. We confirmed the 





Surface-modified WO3/Pt nanoparticles remain chemically active. 
We tested the catalytic activity of FA-PEG, FA-PLL, and FA-PVA WO3/Pt nanoparticles by 
monitoring the production of hydroxyl radicals using coumarin as a fluorescent probe. 
Nanoparticles were illuminated with coumarin for 90 minutes. Aliquots were sampled at eight 
different time points and assessed for fluorescence (332/460). Catalytic activity of nanoparticles 
was measured before and after surface modification. We found that FA-PEG and FA-PLL 
nanoparticles retain their ability to synthesize hydroxyl radicals after surface modification 
(Figures 7 and 8). By contrast, FA-PVA modified nanoparticles did not significantly produce 






Semiconductors have a wide variety of applications, ranging from microchips to solar cells. 
Recently, semiconductors have been used in implantable medical devices to monitor glucose 
levels in diabetics.4 In this study, we go a step further by developing an injectable nanoscale 
semiconductor for potential use as a targeted cancer therapeutic. Specifically, we examine the 
properties of WO3/Pt nanoparticles, which show promise for treating cancer via generation of 
cytotoxic ROS. 
First, we optimized WO3/Pt nanoparticles for ROS yield by examining the effect of crystal 
structure and platinization pH on ROS catalysis. WO3/Pt nanoparticles exist as orthorhombic or 
tetragonal crystal structures, and the arrangement of atoms in the WO3/Pt crystal lattice affects 
the availability of catalytic sites on WO3/Pt surfaces. We found that orthorhombic WO3/Pt 
nanoparticles exhibit higher ROS yields compared to tetragonal WO3/Pt nanoparticles, 
suggesting that orthorhombic crystal structures allow for more oxygen vacancies which function 
as active sites for substrate binding (Figure 2). Moreover, we tested the effect of platinization pH 
on nanoparticle catalysis. Chloroplatinic acid was added to a suspension of WO3 nanoparticles 
in pH 2, pH 12, and no buffer. WO3 nanoparticles platinized at more basic pH have higher 
catalytic activity compared to WO3 platinized at acidic pH. We believe that a basic pH 
destabilizes chloroplatinic acid, facilitating electron transport required for platinum deposition 
(Figure 3). Control WO3 nanoparticles are poor photocatalysts due to the lack of platinum 
construct. Platinum helps trap electrons at the photocathode for the reduction of oxygen to 
hydroxyl radicals. We concluded that orthorhombic WO3 nanoparticles platinized at basic pH are 
most suitable for use as experimental therapeutic photocatalysts. These nanoparticles were 
used in all subsequent studies. 
After establishing a protocol for optimizing the ROS yield of WO3/Pt nanoparticles, we 
studied the substrate specificity of WO3/Pt. Our results show that WO3/Pt nanoparticles extract 
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electrons from a wide variety of biomolecules to synthesize hydroxyl radicals. In particular, 
WO3/Pt nanoparticles showed a high affinity for precursors to nucleic acids (uridine), amino 
acids (lysine, arginine), and metabolites (glucose, glycerol, oxalic acid, citric acid), suggesting 
that WO3/Pt nanoparticles could interfere with key metabolic pathways including, but not limited 
to, the Krebs cycle, glycolysis, and protein synthesis (Figure 5). By sabotaging these vital 
metabolic pathways and destroying the constituents of tumor cells, WO3/Pt nanoparticles could 
accelerate tumor cell failure. Moreover, WO3/Pt nanoparticles have been shown to scavenge 
NADPH, a substrate for glutathione synthesis which participates in oxidant defense.3 As such, 
WO3/Pt nanoparticles not only produce ROS, but also weaken a tumor cell’s ability to deflect an 
oxidant attack. Finally, the wide scope of biological substrates for WO3/Pt nanoparticles 
provides an abundant supply of electrons for ROS synthesis. Therefore, we expect WO3/Pt 
nanoparticles to be highly effective at inducing tumor cell apoptosis in vivo. These results were 
confirmed in animal studies, whereby injection of 4T1 cancer cells treated with WO3/Pt 
nanoparticles into the anterior chamber of a mouse eye reduced tumor growth and extended 
lifetimes of mice.3 
With confirmation that WO3/Pt nanoparticles would be effective in vivo catalysts, we 
focused on developing a delivery platform to target WO3/Pt nanoparticles to cancer cells while 
keeping them chemically active. Using CDI, we successfully coupled FA-PEG to the surface of 
WO3/Pt nanoparticles, which was confirmed by both immunofluorescence and gel 
electrophoresis (Figure 6). As expected, FA-PEG coated nanoparticles migrated a shorter 
distance through the gel matrix than unmodified nanoparticles due to the hydrophobicity of the 
long carbon chain in FA-PEG, which reduces the overall surface charge of WO3/Pt. Moreover, 
under microscope, modified nanoparticles stained with mouse anti folic acid antibody and Alexa 
Fluor 488 goat anti mouse antibody appeared fluorescent (Figure 4C). These data suggest that 
conjugation of FA-PEG to the surface of WO3/Pt nanoparticles was successful.  
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After validating the linkage of FA-PEG to WO3/Pt nanoparticles, we compared the 
catalytic activity of WO3/Pt nanoparticles before and after surface modification using coumarin to 
track hydroxyl radical production. We found that surface modification of WO3/Pt nanoparticles 
did not abolish catalytic activity. In fact, FA-PEG WO3/Pt nanoparticles retained one half of their 
catalytic activity compared to control unmodified WO3/Pt nanoparticles (Figure 7). Partial loss of 
activity could be due to the thick polymer coat of FA-PEG that blocks substrates from reaching 
the nanoparticle catalytic site, thus inhibiting hydroxyl production. However, when incubated 
with 4T1 cancer cells, FA-PEG WO3/Pt nanoparticles did not bind specifically to cancer cells 
(data not shown).    
To improve the tumor specificity of WO3/Pt nanoparticles, we attempted to increase the 
density of FA on the surface of WO3/Pt nanoparticles. We searched for polymers with a high 
content of amine functional groups, which are reaction sites for the covalent linkage of FA-NHS 
ester. Polyvinylamine (PVA) and poly-L-lysine (PLL) were used as linker molecules to increase 
the surface density of FA on WO3/Pt nanoparticles (Figure 6A). FA was most abundant on FA-
PVA modified WO3/Pt nanoparticles (data not shown). 
We compared the catalytic activity of FA-PVA and FA-PLL WO3/Pt nanoparticles. We 
found that FA-PLL WO3/Pt generated more hydroxyl radicals than FA-PVA WO3/Pt, suggesting 
that FA-PLL would be more effective in vivo catalysts. Indeed, when tested in a model of breast 
cancer metastasis to the anterior chamber, FA-PLL nanoparticles selectively accumulated at 
tumors and induced tumor cell apoptosis under illumination.10 Importantly, we demonstrated that 
targetable WO3/Pt nanoparticles do not lose their ability to synthesize ROS after modification, 
and we optimized ROS yield and targeting efficiency by controlling both ligand type and surface 
density. Therefore, WO3/Pt nanoparticles show promise for precise tumor treatment. By 
specifically localizing to nanometer sized regions in cancer cells, WO3/Pt nanoparticles could 
locally manufacture ROS and spare healthy peripheral tissue from ROS-mediated damage. 
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Conventional ROS-based cancer such as radiotherapy and photodynamic therapy do not offer 
such specificity. 
Remarkably, targetable WO3/Pt nanoparticles could prove invaluable for eradicating 
cancer stem cells. Unlike other cells, cancer stem cells overexpress aldehyde dehydrogenase, 
an enzyme capable of detoxifying aldehydes which are produced via the lipid peroxidation 
pathway.10 Although hydroxyl radicals generated by WO3/Pt nanoparticles contribute to the lipid 
peroxidation pathway, aldehyde dehydrogenase enables cancer stem cells to resist nanoparticle 
treatment (Figure 9). However, combining WO3/Pt nanoparticles with aldehyde dehydrogenase 
inhibitors could make cancer stem cells more vulnerable to treatment. Thus, by reducing cancer 
stem cell survival, WO3/Pt nanoparticles could prevent tumor recurrence and eventually improve 
patient outcomes.  
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  Figure 1. Photocatalytic reactions on WO3/Pt nanoparticle surfaces 
WO3/Pt nanoparticles extract electrons from organic donors at the photoanode. Visible light 
excites electrons from the valence band to the conduction band where they are trapped by 
platinum and used to reduce oxygen into hydroxyl radicals at the photocathode. 
Figure 2. WO3/Pt crystal structure affects ROS catalysis. 
We evaluated the catalytic activity of different crystal structures of WO3/Pt nanoparticles 
using coumarin as a fluorescent probe for hydroxyl radical production. A suspension of 0.5 
mg/mL of WO3/Pt nanoparticles in 1mM coumarin (pH 3) was illuminated for 30 minutes. 
Aliquots were sampled at five different time points and assessed for fluorescence 
(332/460). At 30 minutes, orthorhombic WO3/Pt nanoparticles generate significantly more 




Figure 4. Degradation of Methylene Blue by WO3/Pt nanoparticles 
We monitored the degradation of methylene blue by WO3/Pt nanoparticles over time using 
spectrophotometry. WO3/Pt nanoparticles were added to a solution of methylene blue and 
illuminated with a visible light source. Methylene blue was degraded by WO3/Pt over time. In 
the absence of light or nanoparticles, methylene blue was not degraded (data not shown). 
Figure 3. Platinization pH affects ROS catalysis. 
We tested the effect of pH during platinum deposition on the catalytic activity of WO3/Pt 
nanoparticles. Chloroplatinic acid was added to a suspension of WO3 nanoparticles in pH 2, 
pH 12, and no buffer. Catalytic activity of resulting suspensions of WO3/Pt nanoparticles 
was subsequently measured using a Coumarin assay. Platinum deposition at pH 12 
resulted in significantly increased hydroxyl radical production compared to platinum 






Figure 5. Substrate specificity of WO3/Pt nanoparticles 
We assessed the ability of a panel of biomolecules to act as substrates for WO3/Pt 
nanoparticles in oxygen utilization experiments (n = 3). Arrows indicate the onset of 
illumination. Trace 1: A suspension of 1mg/mL of nanoparticles was illuminated in the 
absence of substrate. Trace 2: A 1 mM lysine solution was illuminated in the absence of 
nanoparticles. Trace 3: A mixture of nanoparticles and lysine was kept in the dark. Trace 4: 
Nanoparticles and lysine were exposed to light. Traces 5–10: Dissolved oxygen was 
measured in a suspension of nanoparticles and 1 mM arginine, 0.1% glucose, 0.1% 
glycerol, 0.1% citric acid, 0.1% oxalic acid and 1 mM uridine, respectively, during 
illumination. The combination of light, nanoparticles and substrate led to the disappearance 
of dissolved oxygen. 
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Figure 6. Conjugation of FA-PEG to WO3/Pt nanoparticles 
A) Carbonyldiimidazole was used to covalently link FA-PEG to WO3/Pt nanoparticles. First, 
nanoparticles were activated by CDI. Next, CDI-activated nanoparticles were reacted with 
FA-PEG amine overnight. B) We confirmed the linkage of FA-PEG to the surface of 
WO3/Pt nanoparticles. Nanoparticles were successively stained with mouse anti folic acid 
antibody and Alexa Fluor 488 goat anti mouse antibody and visualized using 
immunofluorescence microscopy. C) Modified and unmodified nanoparticles were run in a 
0.4% agarose gel at 60 mA. Lane 1: 25 µg of unmodified nanoparticles. Lane 2: 25 µg of 










   
Figure 7. Photocathodic activity of FA-PEG WO3/Pt nanoparticles 
We monitored hydroxyl radical production at the photocathode using coumarin as a 
fluorescent probe. A suspension of 0.5 mg/mL of WO3/Pt nanoparticles in 1mM 
coumarin (pH 3) was illuminated for 90 minutes (n = 3). Aliquots were sampled at eight 
different time points and assessed for fluorescence (332/460) using a fluorometer. The 
procedure was repeated after conjugation of FA-PEG to WO3/Pt nanoparticles (n = 2). 




      
Figure 8. Photocathode activity of FA-PVA and FA-PLL nanoparticles 
A) Polyvinylamine (left) offers the highest content of amine functional groups 
compared to poly-L-lysine (right). Amines are reaction sites for the conjugation of 
FA-NHS ester. Therefore, FA-PVA nanoparticles have a higher density of tumor 
targeting ligand FA. B) We assessed the photocathodic activity of modified and 
unmodified nanoparticles using a coumarin assay. A suspension of 0.5 mg/mL 
WO3/Pt nanoparticles in 1mM Coumarin was illuminated for 90 minutes (n = 3). 
Aliquots were sampled at eight different time points and assessed for fluorescence 
(332/460) using a fluorometer. The procedure was repeated for FA-PVA WO3/Pt 
(n = 3) and FA-PLL WO3/Pt (n = 1). At 90 minutes, FA-PLL WO3/Pt generated 













Figure 9. Biochemical pathways affected by WO3/Pt nanoparticles 
WO3/Pt nanoparticles generate hydroxyl radicals from NADPH and other biological 
substrates. As a result, WO3/Pt nanoparticles inhibit glutathione synthesis and reduce 
oxidant defense. Moreover, WO3/Pt nanoparticles contribute to the lipid peroxidation 
pathway which produces toxic aldehydes (from Clark et al., 2015). 
